Clinical Trial Update: A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ruxolitinib in combination with chemotherapy in children with acute lymphoblastic leukemia has completed enrollment and reported resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Leukemia | Phase 2 | Status: COMPLETED